Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.

Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays breast cancer 1, early onset (Tag) Articles ...

A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
Medline, Breast cancer research and treatment, 28-Jul-2017
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Medline, BMC cancer [17] 496, 27-Jul-2017
Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age.
Medline, Radiology and oncology [51] 187-194, 27-Jul-2017

  This Weeks breast cancer 1, early onset (Tag) Articles ...

Put Your Mark Where Your Damage Is: Acetyl-CoA Production by ACLY Promotes DNA Repair.
Medline, Molecular cell [67] 165-167, 23-Jul-2017
BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Medline, EMBO molecular medicine, 23-Jul-2017
Management of Breast Cancer Risk in Women with Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations.
Medline, Annals of surgical oncology, 23-Jul-2017
Molecular analysis of BRCA1 and BRCA2 genes by next generation sequencing and ultrastructural aspects of breast tumor tissue.
Medline, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie [58] 445-455, 23-Jul-2017
Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.
Medline, JAMA oncology, 22-Jul-2017
Flexible Small Molecular Anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold Targets Multiple Estrogen Receptor Conformations.
Medline, Cell cycle (Georgetown, Tex.) 0, 22-Jul-2017
Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Medline, Breast cancer research : BCR [19] 83, 22-Jul-2017
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
Medline, Clinical cancer research : an official journal of the American Association for Cancer Research, 22-Jul-2017
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer.
Medline, NPJ breast cancer [2] 16002, 22-Jul-2017
Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).
Medline, Genetics in medicine : official journal of the American College of Medical Genetics, 22-Jul-2017
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Medline, Genetics in medicine : official journal of the American College of Medical Genetics, 22-Jul-2017
SABCS 2016: systemic therapy for metastatic breast cancer.
Medline, Memo [10] 86-89, 22-Jul-2017
Molecular Tests for the Choice of Cancer Therapy.
Medline, Current pharmaceutical design, 21-Jul-2017
Hsa-miR-520d-5p promotes survival in human dermal fibroblasts exposed to a lethal dose of UV irradiation.
Medline, NPJ aging and mechanisms of disease [2] 16029, 21-Jul-2017
UW Study Examines Prevalence of Non-Founder BRCA1, BRCA2, Other Mutations in Breast Cancer
http://feeds.genomeweb.com, , 20-Jul-2017
Why do BRCA1 mutations cause predominantly breast and ovarian cancer?
http://www.bionity.com, , 20-Jul-2017

  Older breast cancer 1, early onset (Tag) Articles ...

Pitfalls in genetic testing: a case of a SNP in primer-annealing region leading to allele dropout in BRCA1.
Medline, Molecular genetics & genomic medicine [5] 443-447, 20-Jul-2017
Showing Records 0 ... 20  

The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts


Name: breast cancer 1, early onset (Tag)
Type: Gene/Protein



Must Mention A:

In Context:


Show Most Frequent

Optional, Only Include Source:


[Not available (Why?)]